CAD 0.9
(5.88%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -87.82 Million USD | -233.58% |
2022 | 65.74 Million USD | -25.27% |
2021 | 87.97 Million USD | 50.89% |
2020 | 58.3 Million USD | 270.2% |
2019 | -34.25 Million USD | -520.89% |
2018 | 8.13 Million USD | 18424.11% |
2017 | -44.41 Thousand USD | -32.08% |
2016 | -33.62 Thousand USD | -151.03% |
2015 | 65.89 Thousand USD | 228.76% |
2014 | -51.17 Thousand USD | 66.89% |
2013 | -154.55 Thousand USD | 50.21% |
2012 | -310.42 Thousand USD | 18.15% |
2011 | -379.27 Thousand USD | 2.36% |
2010 | -388.43 Thousand USD | 17.98% |
2009 | -473.6 Thousand USD | 20.52% |
2008 | -595.88 Thousand USD | 11.69% |
2007 | -674.72 Thousand USD | 32.81% |
2006 | -1 Million USD | 35.46% |
2005 | -1.55 Million USD | -252.61% |
2004 | -441.25 Thousand USD | -43.5% |
2003 | -307.49 Thousand USD | -134.87% |
2002 | -130.91 Thousand USD | -26.78% |
2001 | -103.26 Thousand USD | 70.58% |
2000 | -350.98 Thousand USD | -41.3% |
1999 | -248.4 Thousand USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 29.16 Million USD | 7.62% |
2024 Q2 | 32.38 Million USD | 11.03% |
2023 Q3 | -107.75 Million USD | -902.19% |
2023 Q4 | 27.09 Million USD | 125.15% |
2023 Q2 | -10.75 Million USD | -399.83% |
2023 FY | -87.82 Million USD | -233.58% |
2023 Q1 | 3.58 Million USD | 271.33% |
2022 Q2 | 31.42 Million USD | 55.04% |
2022 Q4 | -2.09 Million USD | -112.89% |
2022 FY | 65.74 Million USD | -25.27% |
2022 Q1 | 20.26 Million USD | -30.53% |
2022 Q3 | 16.24 Million USD | -48.31% |
2021 Q3 | -264.01 Million USD | -1875.27% |
2021 Q4 | 29.17 Million USD | 111.05% |
2021 FY | 87.97 Million USD | 50.89% |
2021 Q1 | 16.23 Million USD | -29.19% |
2021 Q2 | 14.87 Million USD | -8.41% |
2020 Q4 | 22.93 Million USD | -29.5% |
2020 FY | 58.3 Million USD | 270.2% |
2020 Q2 | 20.39 Million USD | 227.6% |
2020 Q3 | 32.52 Million USD | 59.52% |
2020 Q1 | -15.98 Million USD | 38.25% |
2019 Q3 | -5.62 Million USD | -220.19% |
2019 FY | -34.25 Million USD | -520.89% |
2019 Q2 | 4.68 Million USD | 171.9% |
2019 Q4 | -25.87 Million USD | -360.04% |
2019 Q1 | -6.5 Million USD | -691.19% |
2018 Q3 | -65.71 Thousand USD | -1058.9% |
2018 Q1 | -11.85 Thousand USD | 46.52% |
2018 FY | 8.13 Million USD | 18424.11% |
2018 Q4 | 1.1 Million USD | 1775.46% |
2018 Q2 | -5670.30 USD | 52.17% |
2017 FY | -44.41 Thousand USD | -32.08% |
2017 Q3 | -5456.35 USD | 43.38% |
2017 Q2 | -9636.94 USD | -38.02% |
2017 Q4 | -22.17 Thousand USD | -306.34% |
2017 Q1 | -6982.42 USD | 55.78% |
2016 Q2 | -10.55 Thousand USD | -37.27% |
2016 Q3 | -361.88 USD | 96.57% |
2016 Q4 | -15.79 Thousand USD | -4263.57% |
2016 FY | -33.62 Thousand USD | -151.03% |
2016 Q1 | -7690.10 USD | 44.55% |
2015 Q4 | -13.86 Thousand USD | -47.52% |
2015 FY | 65.89 Thousand USD | 228.76% |
2015 Q3 | -9400.97 USD | -108.77% |
2015 Q2 | 107.24 Thousand USD | 1130.8% |
2015 Q1 | -10.4 Thousand USD | 12.62% |
2014 Q3 | -30.08 Thousand USD | -82.45% |
2014 Q1 | -9215.87 USD | 88.59% |
2014 FY | -51.17 Thousand USD | 66.89% |
2014 Q4 | -11.9 Thousand USD | 60.42% |
2014 Q2 | -16.48 Thousand USD | -78.92% |
2013 Q3 | -49.92 Thousand USD | 27.6% |
2013 Q2 | -68.96 Thousand USD | -25.08% |
2013 FY | -154.55 Thousand USD | 50.21% |
2013 Q1 | -55.13 Thousand USD | 29.85% |
2013 Q4 | -80.75 Thousand USD | -61.74% |
2012 FY | -310.42 Thousand USD | 18.15% |
2012 Q3 | -77.82 Thousand USD | -32.35% |
2012 Q2 | -58.8 Thousand USD | 48.51% |
2012 Q1 | -114.19 Thousand USD | -12.52% |
2012 Q4 | -78.59 Thousand USD | -0.98% |
2011 Q2 | -132.67 Thousand USD | -59.16% |
2011 Q1 | -83.35 Thousand USD | 77.37% |
2011 Q3 | -66.7 Thousand USD | 49.73% |
2011 Q4 | -101.48 Thousand USD | -52.15% |
2011 FY | -379.27 Thousand USD | 2.36% |
2010 Q3 | 10 Thousand USD | 110.33% |
2010 Q4 | -368.4 Thousand USD | -3781.07% |
2010 FY | -388.43 Thousand USD | 17.98% |
2010 Q2 | -96.9 Thousand USD | -15.24% |
2010 Q1 | -84.09 Thousand USD | 68.18% |
2009 Q3 | -73.7 Thousand USD | -1113.94% |
2009 Q2 | -6071.25 USD | 89.49% |
2009 Q1 | -57.74 Thousand USD | 96.7% |
2009 FY | -473.6 Thousand USD | 20.52% |
2009 Q4 | -264.26 Thousand USD | -258.57% |
2008 FY | -595.88 Thousand USD | 11.69% |
2008 Q4 | -1.75 Million USD | -2720.03% |
2008 Q2 | -66.89 Thousand USD | 66.95% |
2008 Q1 | -202.37 Thousand USD | -1527.6% |
2008 Q3 | -62.12 Thousand USD | 7.12% |
2007 FY | -674.72 Thousand USD | 32.81% |
2007 Q4 | -12.43 Thousand USD | 86.49% |
2007 Q3 | -92.06 Thousand USD | 79.21% |
2007 Q2 | -442.92 Thousand USD | -503.49% |
2007 Q1 | -73.39 Thousand USD | 87.71% |
2006 Q3 | -111.17 Thousand USD | 30.88% |
2006 Q4 | -597.07 Thousand USD | -437.05% |
2006 Q2 | -160.83 Thousand USD | -19.35% |
2006 FY | -1 Million USD | 35.46% |
2006 Q1 | -134.75 Thousand USD | -1076.81% |
2005 Q3 | -1.27 Million USD | -1662.1% |
2005 Q4 | -11.45 Thousand USD | 99.1% |
2005 Q2 | -72.17 Thousand USD | 61.08% |
2005 Q1 | -185.46 Thousand USD | 1.54% |
2005 FY | -1.55 Million USD | -252.61% |
2004 FY | -441.25 Thousand USD | -43.5% |
2004 Q2 | -33.5 Thousand USD | 66.97% |
2004 Q4 | -188.37 Thousand USD | -84.71% |
2004 Q1 | -101.43 Thousand USD | -10.89% |
2004 Q3 | -101.98 Thousand USD | -204.39% |
2003 FY | -307.49 Thousand USD | -134.87% |
2003 Q1 | -26.15 Thousand USD | 52.67% |
2003 Q2 | -21.82 Thousand USD | 16.55% |
2003 Q3 | -164.4 Thousand USD | -653.26% |
2003 Q4 | -91.47 Thousand USD | 44.36% |
2002 Q1 | -19.52 Thousand USD | 0.0% |
2002 FY | -130.91 Thousand USD | -26.78% |
2002 Q4 | -55.26 Thousand USD | -127.14% |
2002 Q3 | -24.33 Thousand USD | 22.03% |
2002 Q2 | -31.2 Thousand USD | -59.83% |
2001 FY | -103.26 Thousand USD | 70.58% |
2000 FY | -350.98 Thousand USD | -41.3% |
1999 FY | -248.4 Thousand USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | -7274.203% |
Ayurcann Holdings Corp. | -3.25 Million CAD | -2601.515% |
Blueberries Medical Corp. | -1.22 Million CAD | -7060.048% |
The BC Bud Corporation | -1.22 Million CAD | -7078.137% |
BioNxt Solutions Inc. | -6.36 Million CAD | -1279.28% |
CordovaCann Corp. | -2.51 Million CAD | -3395.361% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -9873.675% |
Captor Capital Corp. | 655.2 Thousand CAD | 13503.815% |
City View Green Holdings Inc. | -996.45 Thousand CAD | -8713.588% |
1CM Inc. | 300.79 Thousand CAD | 29297.35% |
Global Hemp Group Inc. | -551.7 Thousand CAD | -15818.384% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | -2164.009% |
IM Cannabis Corp. | -12.17 Million CAD | -621.339% |
Lobe Sciences Ltd. | -3.35 Million CAD | -2514.257% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -22291.488% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | -2656.529% |
Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 16295.438% |
Ovation Science Inc. | -764 Thousand CAD | -11395.037% |
Pharmadrug Inc. | -1.33 Million CAD | -6478.438% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | -7590.449% |
RAMM Pharma Corp. | -7.08 Million CAD | -1139.362% |
RIV Capital Inc. | 1.78 Million CAD | 5033.22% |
Revive Therapeutics Ltd. | -3.28 Million CAD | -2572.606% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | -901.511% |
SLANG Worldwide Inc. | -5.98 Million CAD | -1367.041% |
1933 Industries Inc. | -9.34 Million CAD | -839.353% |
Red Light Holland Corp. | -6.44 Million CAD | -1262.35% |
Top Strike Resources Corp. | -784.8 Thousand CAD | -11090.466% |
Xebra Brands Ltd. | -1.55 Million CAD | -5549.46% |
Adastra Holdings Ltd. | -1.79 Million CAD | -4796.031% |